Long-term efficacy and safety of itolizumab in patients with moderate-to-severe chronic plaque psoriasis: A double-blind, randomized-withdrawal, placebo-controlled study

Autor:	Dogra, Sunil, D.S., Krupashankar, Budamakuntla, Leelavathy, Srinivas, C.R., Khopkar, Uday, Gupta, Sandesh, Shetty, Narendra, Pratap, Dasiga Venkata Subrahmanya, Gopal, M.G., Rao, T. Narayana, Garg, Vijay, Sumathy, T.K., Saraswat, Abir, Bhat, Ramesh, Kura, Mahendra, Pandey, Neeraj, Shah, Radha, Sai Krishna, Kotla, Padmaja, Dalavai, Manmohan, G., M.S., Ramakrishnan, Barve, Abhijit, Montero, Enrique
Zdroj:	In Journal of the American Academy of Dermatology August 2015 73(2):331-333
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect